Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Bryant Fong
AddedMar 31, 2024
UpdatedMay 1, 2026
Bryant Fong

Bryant Fong

Board Member, Odyssey Thera

Bryant Fong's Career

Odyssey Thera
Odyssey Thera

San Ramon, CA, US

Board Member· Board
Alinea Pharmaceuticals
Alinea Pharmaceuticals

Cambridge, MA, US

Board Member· Board
Logical Therapeutics
Logical Therapeutics

Waltham, MA, US

Board Member· Board
Nora Therapeutics
Nora Therapeutics

Palo Alto, CA, US

Board Member· Board
AliveCor
AliveCor

Mountain View, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Bryant Fong's Career

Odyssey Thera
Odyssey Thera
Public$6.3M302000San Ramon, CA, US
Board Member· Board

Leadership at Odyssey Thera

Michael PowellMichael PowellFounder
Hugh RienhoffHugh RienhoffBoard Member
John WestwickJohn WestwickBoard Member
Jeremy CaldwellJeremy CaldwellBoard Member

Similar to Odyssey Thera

Odyssey TherapeuticsOdyssey TherapeuticsCambridge, MA, USPrecision Medicine, Therapeuticsest. 2021Odyssey TherapeuticsCambridge, MA, US · est. 2021

Odyssey Therapeutics: Innovating rapid, groundbreaking solutions in precision oncology and inflammation medicine.

Series C · $487M175
Terpenoid TherapeuticsTerpenoid TherapeuticsCoralville, IA, USDrug Developmentest. 2005Terpenoid TherapeuticsCoralville, IA, US · est. 2005

Terpenoid Therapeutics Inc: Innovating cancer cure through biotech-driven drug discovery and development.

Pre-Seed · $1M30
Ascenta TherapeuticsAscenta TherapeuticsMalvern, PA, USCancer Treatmentsest. 2003Ascenta TherapeuticsMalvern, PA, US · est. 2003

Ascenta Therapeutics: A clinical-stage biopharma company innovating new cancer treatments.

Public · $87.8M75
VyriadVyriadRochester, MN, USCancer Treatmentsest. 2016VyriadRochester, MN, US · est. 2016

Omnis Pharma, Inc.: A US-based pharmaceutical company specializing in cancer treatments.

Series B · $63.4M51
Alinea Pharmaceuticals
Alinea Pharmaceuticals
Series A$45M302005Cambridge, MA, US
Board Member· Board

Leadership at Alinea Pharmaceuticals

Nick GalakatosNick GalakatosBoard Member
Dr Edward M ScolnickDr Edward M ScolnickBoard Member
Logical Therapeutics
Logical Therapeutics
Public$79.4M302005Waltham, MA, US
Board Member· Board

Leadership at Logical Therapeutics

Martin EdwardsMartin EdwardsBoard Member
Carolyn GreenCarolyn GreenFounder
Mitchell FinkMitchell FinkCEO
Paul SchmittPaul SchmittBoard Member
Dr Lutz B GiebelDr Lutz B GiebelBoard Member

Similar to Logical Therapeutics

VlstVlstSeattle, WA, USPharmaceuticalsest. 2004VlstSeattle, WA, US · est. 2004

Viral Logic Systems Technology Corp., a US-based pharmaceutical company, specializes in inflammatory treatments.

Public · $55M30
NeuroTherapeutics PharmaNeuroTherapeutics PharmaChicago, IL, USPharmaceuticals, Therapeuticsest. 2006NeuroTherapeutics PharmaChicago, IL, US · est. 2006

NeuroTherapeutics Pharma: A US-based biopharmaceutical firm specializing in neuropathic and acute pain treatments.

Public · $60.7M30
ComplexaComplexaPittsburgh, PA, USTherapeuticsest. 2008ComplexaPittsburgh, PA, US · est. 2008

Complexa, Inc.: A biopharmaceutical firm innovating therapies for inflammatory and metabolic diseases.

Public · $86.9M7
Resolvyx PharmaceuticalsResolvyx PharmaceuticalsCambridge, MA, USTherapeuticsest. 2001Resolvyx PharmaceuticalsCambridge, MA, US · est. 2001

Resolvyx Pharmaceuticals: Developing lipid-based therapeutics for inflammatory diseases.

Seed · $20.7M30
Nora Therapeutics
Nora Therapeutics
Series B$36.8M312007Palo Alto, CA, US
Board Member· Board

Leadership at Nora Therapeutics

Jeffrey TongJeffrey TongBoard Member
Chris McClainChris McClainFounder
David SchnellDavid SchnellBoard Member
Don HaydenDon HaydenBoard Member
Martin VogelbaumMartin VogelbaumBoard Member
Anupam DalalAnupam DalalBoard Member

Similar to Nora Therapeutics

Novoron BioscienceNovoron BioscienceSan Diego, CA, USPharmaceutical Therapiesest. 2014Novoron BioscienceSan Diego, CA, US · est. 2014

Biotech firm specializing in pharmaceutical therapies for central nervous system regeneration.

Seed · $13.8M5
NeuroTherapeutics PharmaNeuroTherapeutics PharmaChicago, IL, USPharmaceuticals, Therapeuticsest. 2006NeuroTherapeutics PharmaChicago, IL, US · est. 2006

NeuroTherapeutics Pharma: A US-based biopharmaceutical firm specializing in neuropathic and acute pain treatments.

Public · $60.7M30
Granata BioGranata BioDuxbury, MA, USBiopharmaceuticalsest. 2018Granata BioDuxbury, MA, US · est. 2018

Fertility biotech firm specializing in innovative solutions for patients.

Series A · $14.1M5
Novita TherapeuticsNovita TherapeuticsOlathe, KS, USDrug Development, Medical Devicesest. 2019Novita TherapeuticsOlathe, KS, US · est. 2019

Novita Therapeutics: A Kansas-based biopharmaceutical firm specializing in early-stage drug and device development.

Series B · $7.7M5
AliveCor
AliveCor
Series F$154.3M1502011Mountain View, CA, US
Board Member· Board

Recent news

DeepRoute raises $100M in push to beat Tesla’s FSD in ChinaTechCrunch · 2024

Leadership at AliveCor

Vinod KhoslaVinod KhoslaBoard Member
Mike KoureyMike KoureyBoard Member
Ryan PhillipsRyan PhillipsBoard Member
G. Steven BurrillG. Steven BurrillBoard Member
Priya AbaniPriya AbaniBoard Member
Bruce SatchwellBruce SatchwellCo-Founder

Bryant Fong's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Bryant Fong

Amir WainAmir WainCEO · i2iJonathan MacQuittyJonathan MacQuittyBoard Member · PersonalisScott RichardsScott RichardsCo-Founder · d2iMasoud VaziriMasoud VaziriFounder · i2iAndrew BankAndrew BankCo-Founder · LarkyDouglas SpitzDouglas SpitzBoard Member · The Hive